cancer Clinical Trials drug development Immunotherapies Zhang group identifies gene that may make triple-negative breast cancer cells vulnerable to existing drug By Staff Reports 2 years ago Certain therapies that have proven effective in treating some types of breast cancers are ineffective
Breast Cancer cancer Cancer Discovery Cancer screening Marine Organisms Hold Promise for Treating Triple Negative Breast Cancer By Staff Reports 2 years ago The oceans cover more than 70 percent of the earth’s surface and provide a rich
Biotechnology Breast Cancer cancer Cancer Discovery Cancer screening Clinical Trials genes New Study Finds Nanoparticles Show Promise in Therapy for Triple-Negative Breast Cancer By Staff Reports 3 years ago Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast
Biotechnology cancer Cell Therapy Osteoporosis Drug Could Be Used to Treat Aggressive Form of Breast Cancer, Researchers Say By Staff Reports 3 years ago Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like
Biotechnology cancer Cell Therapy Immunotherapies Drug Combo Gangs Up to Take on Triple-Negative Breast Cancer By Staff Reports 4 years ago Researchers find novel combination disrupts multiple factors in aggressive type of cancer In the hunt
cancer Clinical Trials Diabetes Diabetes Drug May Be Effective Against Deadly Form of Breast Cancer, Study Suggests By Staff Reports 4 years ago Researchers in China have discovered that a metabolic enzyme called AKR1B1 drives an aggressive type
Biotechnology cancer Immunotherapies UH Seidman Cancer Center Expert Presents Novel Triple-Negative Breast Cancer Immunotherapy Trial at 2016 San Antonio Breast Cancer Symposium By Staff Reports 4 years ago Meeting focuses on state-of-the-art breast cancer research, including immunotherapeutic approaches A researcher from University Hospitals
cancer NUS Scientists Discover The “Switch” That Makes Breast Cancer Cells Aggressive By Staff Reports 4 years ago A team of scientists from the National University of Singapore (NUS) has established novel insights
cancer Phosphorylated-p68 Drug With Efficacy in 100 Cancer Cell Lines to Target Triple Negative Breast Cancer By Staff Reports 5 years ago Drugs that target and destroy phosphorylated-p68 (P-p68), an RNA helicase, have the potential to kill
cancer Inhibition of β2-Adrenergic Receptor Reduces Triple-Negative Breast Cancer Brain Metastases: The Potential Benefit of Perioperative β-Blockade. By Staff Reports 5 years ago While we look to invent new medicines to treat cancer, a parallel approach to repurpose